Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza B Challenge Dose-Finding Study
NCT06254820Phase 2Recruiting
- Sponsor
- hVIVO
- Start
- Oct 2023
- Primary completion
- Feb 2024
- Countries
- 1
01
Overview
Phase 2, randomised trial in influenza B (4 arms), sponsored by hVIVO. Primary endpoint: Occurrence of AEs and SAEs. Started Oct 2023; status: recruiting.
02
Conditions
influenza B
Beyond the preview
Go deeper on NCT06254820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06254820.